VT
Description
I am a scientist-turned-entrepreneur passionate about transforming cancer care through innovation. I am Co-founder, President and Chief Scientific Officer of METHYS Dx, a precision oncology company developing liquid biopsy solutions for cancer patient monitoring. I am also Co-founder of emulseo, a company providing cutting-edge microfluidic solutions allowing to accelerate innovation in life sciences.
My entrepreneurial journey builds on more than two decades of research at the intersection of molecular biology, microfluidics and cancer diagnostics. Together with a broad network of collaborators, I have contributed to the development of pioneering technologies, including droplet digital PCR, now widely used for the ultra-sensitive detection of biomarkers.
My mission is to bridge research, innovation and impact by developing non-invasive diagnostic tools that enable earlier cancer detection and more personalized patient monitoring. I strongly believe that meaningful innovation emerges from collaboration. This is why I work closely with clinicians, researchers and industry partners worldwide to advance precision medicine and improve outcomes for people affected by cancer.
Loading